5 (33%) patients with IDH1-mut tumours and 6 (8%) patients without IDH1-mut had at most one impaired result on cognitive tests; impaired results on 2–4 tests had 5 (33%) vs. 21 (28%). Here, IDH1 is linked to neoplasm.